Source: International Congress 2019 – Basic research of airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Vignoli (Florence, Italy), G. Santini (Rome, Italy), L. Tenori (Florence, Italy), F. Macagno (Rome, Italy), G. Macis (Rome, Italy), N. Mores (Rome, Italy), T. Higenbottam (London, United Kingdom), C. Luchinat (Florence, Italy), P. Montuschi (Rome, Italy). A NMR-based metabolomics approach to the assessment of inhaled pharmacotherapy in patients with COPD. 3585

Member's Comments

No comment yet.

Related content which might interest you: NMR-based metabolomics of exhaled breath condensate for assessing the effects of inhaled corticosteroids in COPD patients Source: International Congress 2017 – Management of COPD Year: 2017 Clustering approach and effects of inhaled therapy on breath-fingerprint of newly diagnosed COPD patients: an e-nose based study Source: International Congress 2017 – Innovation in COPD: techniques and facts Year: 2017 A personalised medicine approach to ICS use in COPD Source: International Congress 2019 – Personalised medicine in COPD: Matching the patient needs with the right care Year: 2019 Metabolomics identifies biomarkers of exacerbations in smokers with and without COPD Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases Year: 2020 A realistic study assessing inhaled treatment compliance in COPD patients Source: Eur Respir J 2001; 18: Suppl. 33, 25s Year: 2001 Role of biomarkers in the assessment and phenotyping asthma and COPD Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases Year: 2017 Methodological issues in therapeutic trials of COPD Source: Eur Respir J 2008; 31: 927-933 Year: 2008 A network-based approach to defining phenotypes in COPD Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Metabolomic fingerprinting in the identification of biomarkers in COPD patients Source: Annual Congress 2012 - Basic and translational studies in COPD Year: 2012 Clinical clustering of COPD patients is useful to predict future COPD exacerbations Source: International Congress 2018 – New predictors of morbidity and mortality in COPD Year: 2018 Effects of treatment and withdrawal with inhaled beclomethasone/formoterol on electronic nose and NMR metabolomic breathprints in patients with COPD Source: International Congress 2016 – Airway biomarkers Year: 2016 Application of omics technologies to the identification of biomarkers for COPD Source: Annual Congress 2007 - Cell biology of asthma and COPD Year: 2007 Magnetocardiographic assessment of therapeutic efficacy of β2–agonists and corticosteroids in patients with COPD and bronchial asthma Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma Year: 2008 FENO as a biomarker guide for inhaled corticosteroid step down in patients with mild-to-moderate well-controlled asthma Source: Eur Respir J, 55 (5) 2001319; 10.1183/13993003.01319-2020 Year: 2020 Efficiency of different approaches for the assessment of the risk of exacerbations in patients with COPD Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 Training-induced effects on plasma metabolomics in patients with COPD Source: Annual Congress 2008 - Discovery of novel targets in lung disease by means of functional genomics Year: 2008 Effects of topical therapy on the breath pattern of patients with newly diagnosed COPD: An e-nose based study Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015 Why inflammatory phenotyping is necessary for successful drug evaluation in asthma and COPD Source: Eur Respir J 2013; 42: 891-892 Year: 2013 Extent of inhaled drug deposition in mouth-throat and pulmonary airways: A novel biophysical modelling approach for inhaled therapeutics Source: International Congress 2015 – New models for treating airway diseases Year: 2015 Developing evidence-based recommendations regarding inhalation technique in patients with COPD Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more Year: 2020